Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : LLY crawled time : 13:30 save search
Lilly Completes Acquisition of POINT Biopharma
Published: 2023-12-27 (Crawled : 13:30) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.03%
H: 2.31%
C: 1.93%
biopharma acquisition
Rigel Announces Publication of Data from Phase 2 Clinical Study of Fostamatinib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia in the American Journal of Hematology
Published: 2022-03-08 (Crawled : 13:30) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.38%
H: 0.0%
C: 0.0%
RIGL | $1.07 1.91% 1.87% 810K
|
Health Technology
|
| O: -1.78%
H: 8.93%
C: 3.63%
america treatment ema phase 2 anemia antibody
Centessa Pharmaceuticals Expands Management Team and Adds to Extensive Development Expertise
Published: 2022-03-07 (Crawled : 13:30) - biospace.com/
CNTA | $10.555 0.24% 0.24% 150K
|
Manufacturing
|
| O: -8.81%
H: 10.7%
C: -3.99%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 2.08%
H: 0.0%
C: 0.0%
als
Clinical Catch-Up: Covaxin, Celyad Hold, CRISPR's Next Step
Published: 2022-03-07 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 7.22%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 2.08%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 1.56%
H: 0.0%
C: 0.0%
DRRX | $0.9019 -0.89% -0.9% 110K
|
Health Technology
|
| O: -1.84%
H: 1.67%
C: -7.94%
xin crispr cel
Veru to Present at the Oppenheimer 32nd Annual Healthcare Conference on March 15-17, 2022
Published: 2022-03-01 (Crawled : 13:30) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
VERU | $1.305 -8.1% -8.81% 2.6M
|
Health Technology
|
| O: -2.78%
H: 1.25%
C: -0.54%
health thc conference
Benign Prostatic Hyperplasia Therapeutics Market to Reach $9.39 Bn, Globally, by 2030 at 5.0% CAGR: Allied Market Research
Published: 2022-02-22 (Crawled : 13:30) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: -0.57%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.59%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 1.84%
H: 0.49%
C: 0.09%
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: -0.61%
H: 1.05%
C: -0.86%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.93%
H: 0.77%
C: 0.12%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.46%
H: 0.69%
C: -0.03%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.21%
H: 2.39%
C: 0.83%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.26%
H: 0.81%
C: 0.46%
research therapeutics
QBREXZA® (Rapifort® Wipes 2.5%) Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Milestone Payment to Journey Medical Corporation
Published: 2022-02-11 (Crawled : 13:30) - globenewswire.com
DERM | $3.45 -3.63% -3.77% 100K
|
|
| O: 0.76%
H: 3.98%
C: -0.95%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
qbrexza approval corporation one milestone
BioSpace Movers & Shakers, Jan. 14
Published: 2022-01-14 (Crawled : 13:30) - biospace.com/
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.67%
H: 3.62%
C: 3.62%
PPG A | $130.9 -3.12% 0.0% 4.5M
|
Process Industries
|
| O: -2.07%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
AMRX | $5.42 1.12% 1.11% 1.1M
|
Health Technology
|
| O: -1.71%
H: 0.0%
C: 0.0%
PHAT | $8.98 -5.27% -5.57% 590K
|
Health Technology
|
| O: -3.08%
H: 0.0%
C: 0.0%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
space spac
Bluestar Genomics Appoints David Mullarkey Chief Executive Officer
Published: 2022-01-10 (Crawled : 13:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.28%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
Verge Genomics to Present at 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022
Published: 2022-01-06 (Crawled : 13:30) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -2.81%
H: 0.0%
C: 0.0%
health genomics genomic thc conference j.p. morgan healthcare conference
BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
Published: 2021-12-30 (Crawled : 13:30) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.28%
H: 0.52%
C: -0.69%
BYSI | $1.8 -2.21% 80K
|
Health Technology
|
| O: -2.52%
H: 10.33%
C: 9.15%
financial results results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.